Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Blood|May 9, 2012
BMP9 and BMP10 are critical for postnatal retinal vascular remodelingNicolas Ricard, Delphine Ciais, Sandrine Levet, et al.
International Journal of Cancer|March 9, 2018
MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancerClaire Agosta, Jonathan Laugier, Laurent Guyon, et al.
Oncotarget|March 7, 2015
A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasAgnès Desroches-Castan, Delphine Quélard, Martine Demeunynck, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic FibrosisAgnès Desroches-Castan, Emmanuelle Tillet, Nicolas Ricard, et al.
The Journal of Infectious Diseases|November 26, 2002
Implication of transforming growth factor-beta1 in Chagas disease myocardiopathyTania C Araújo-Jorge, Mariana C Waghabi, Alejandro M Hasslocher-Moreno, et al.
Blood|June 7, 2013
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formationSandrine Levet, Delphine Ciais, Galina Merdzhanova, et al.
Memorias Do Instituto Oswaldo Cruz|March 3, 2022
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas diseaseMariana Caldas Waghabi, Roberto Rodrigues Ferreira, Rayane da Silva Abreu, et al.
Plos Neglected Tropical Diseases|June 22, 2012
Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas diseaseFabiane L de Oliveira, Tania C Araújo-Jorge, Elen M de Souza, et al.
Pageof 9